STOCKTON, CALIFORNIA/June 11, 2013 / Newswire/ — Viratech Corp. (OTC:VIRA) announced today that Cancer.im’s 5th book of 235 books slated to be released on Amazon’s Kindle platform, focusing on Cancer, has achieved best-seller status for Oncology.
The book, Breath Analysis for Detection of Diseases and their Causes by Dr. Kevin Buckman and Cancer Patient Advocate Chris Ryan, has achieved number 1 best-seller status for Oncology. The first book, Find and Stop Breast Cancer, became a best seller earlier this year after only three days. The book Breath Analysis for Detection of Diseases and their Causes can be bought here:http://www.amazon.com/Analysis-Detection-diseases-Cancer-im-ebook/dp/B00D6PEJCG/ref=sr_1_1?s=books&ie=UTF8&qid=1370469541&sr=1-1
Breath Analysis for Detection of Diseases and their Causes is the result of decades of research in the field of cancer.
Breath analysis is a method for non-invasive tests on the clinical state of an individual by monitoring volatile organic compounds (VOC’s) present in the exhaled breath of humans and animals. Breath gas concentration can then be related to blood concentrations via calculations, for example in blood alcohol and other kinds of testing.
Modern breath testing commenced in 1971, when Nobel Prize winner Linus Pauling demonstrated that human breath is a complex gas, with over 200 different volatile organic compounds. Physicians have used breath analysis since the days of the ancient Greek scientists, and now there are some 3,481 compounds in breath exhalation that can be measured and more are being discovered.
Volatile organic compounds (VOCs) are made inside the body from the human chemical system as a result of certain exposures to chemicals, normal metabolic activity, or due to disease states. They enter the body and are eventually metabolized or excreted via exhalation, skin emission, urine, sweat, tears, or other body fluids or secretions.
Health care in the US now costs over $2 trillion a year. Some health experts believe that we are now in a downward trend in our ability to cover health care costs. Breath sampling is non-invasive and breath samples can be tested frequently due to low cost. Finding of potential disease biomarkers can be obtained by analysis of exhaled breath. There are many applications for medical diagnosis, finding the underlying problems with disease, all allow for therapy and prevention of disease and pre-disease states. With frequent testing, this can allow for monitoring of various treatment options.
According to the book, “Cancer.im (www.cancer.im) is working to find new screening tests for cancer and new modes of therapy. The site, which launched on February 15, 2013, includes a user friendly Mission Adaptive Plan (a MAP) that can be tailored for each user, and 15 modules for dealing with the disease, which are based on the Robert Ryan Cancer Protocol. Based on more than 19 medical studies on quality of life and associated longevity, following the Robert Ryan Cancer Protocol decreases the morbidity of cancer by increasing the quality of life by the use of these 15 steps which allows a cancer patient to be proactive. There is no charge for this service.” An explanatory video of the power of a Cancer Support Social Network can be seen here: http://www.youtube.com/watch?v=dz1tHRb3wvU
About Cancer.im
Through its experience-based search engine and technology, Cancer.im’s goal is to become the primary resource on the web for people affected by cancer, for the purpose of making a difference in their own lives and the lives of others. Cancer.im’s mission is to empower every cancer patient with the ability to research their disease and to find, organize, and manage their own cancer support network at no charge to them. The goal of these support networks is to assist the patient in conserving needed energy by reducing the burden associated with their own daily trials and tribulations. Cancer.im will strive to convert this saved energy into a higher level of patient activity and a stronger determination to fight their disease.
In addition Cancer.im is seeking new cancer researchers who wish to leverage its intellectual property and social network platform for the purpose of creating new distribution and engagement channels.
About Viratech Corp.
Viratech Corp. has created the first open source biotech research social network platform. The purpose of the platform is to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. This has been made possible by leveraging social collaboration in a way that allows new biotech ventures the ability to protect their intellectual property, then simultaneously allowing those same ventures the ability to promote and crowdsource their development.
Contact: Kevin Buckman MD
Viratech, Corp.
http://viratech.org
Email Contact: info@viratech.org